Strategic Acquisition Following the acquisition by JRS in 2023, there is a clear path for cross-selling opportunities within the expanded portfolio of plant-based functional ingredients, hydrocolloids, and seaweed extracts to mutual customers.

Diversified End Markets Algaia serves Food, Nutraceutical, Personal Care, Medical Device, Pharmaceutical, and Agriculture sectors, presenting multiple entry points for upsell of seaweed-based extracts and biostimulants to existing and new customers across industries.

Sustainability Focus Emphasize natural, sustainable seaweed-derived products as a value proposition to eco-conscious brands, enabling partnerships with retailers and brands prioritizing sustainability credentials and clean-label ingredients.

Growth Initiatives Leverage recent distribution partnerships and channel expansion to identify distributors and strategic partners in regions where Algaia has growth potential, accelerating market penetration for hydrocolloids and algae-based solutions.

Innovation & R&D Services Algaia Services offers R&D analytics on micro- and macro-algae biomass, enabling collaboration opportunities with manufacturers seeking customization, quality control, or feasibility studies for new algae-based product lines.